LivaNova PLC (NASDAQ:LIVN) Shares Sold by United Services Automobile Association

Share on StockTwits

United Services Automobile Association cut its holdings in LivaNova PLC (NASDAQ:LIVN) by 13.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,938 shares of the company’s stock after selling 1,347 shares during the quarter. United Services Automobile Association’s holdings in LivaNova were worth $643,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Voloridge Investment Management LLC acquired a new position in LivaNova in the second quarter valued at $2,356,000. Nuveen Asset Management LLC increased its stake in LivaNova by 262.1% in the second quarter. Nuveen Asset Management LLC now owns 357,653 shares of the company’s stock valued at $25,737,000 after purchasing an additional 258,882 shares during the period. Price T Rowe Associates Inc. MD increased its stake in LivaNova by 18.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,395,068 shares of the company’s stock valued at $172,349,000 after purchasing an additional 378,564 shares during the period. UBS Asset Management Americas Inc. increased its stake in LivaNova by 22.9% in the second quarter. UBS Asset Management Americas Inc. now owns 1,390,299 shares of the company’s stock valued at $100,046,000 after purchasing an additional 259,369 shares during the period. Finally, D. E. Shaw & Co. Inc. increased its stake in LivaNova by 1,661.4% in the second quarter. D. E. Shaw & Co. Inc. now owns 392,149 shares of the company’s stock valued at $28,219,000 after purchasing an additional 369,885 shares during the period. Institutional investors own 88.20% of the company’s stock.

Shares of LivaNova stock opened at $70.90 on Friday. LivaNova PLC has a 52-week low of $64.80 and a 52-week high of $126.99. The company has a quick ratio of 0.67, a current ratio of 0.95 and a debt-to-equity ratio of 0.15. The company’s 50-day simple moving average is $76.76 and its 200-day simple moving average is $75.42. The firm has a market cap of $3.37 billion, a price-to-earnings ratio of 25.67, a price-to-earnings-growth ratio of 2.72 and a beta of 0.54.

LivaNova (NASDAQ:LIVN) last issued its earnings results on Wednesday, July 31st. The company reported $0.56 earnings per share for the quarter, missing the consensus estimate of $0.59 by ($0.03). LivaNova had a positive return on equity of 8.56% and a negative net margin of 23.86%. The company had revenue of $277.20 million for the quarter, compared to analyst estimates of $275.14 million. During the same quarter in the previous year, the company posted $0.96 earnings per share. The company’s quarterly revenue was down 3.6% compared to the same quarter last year. Equities research analysts anticipate that LivaNova PLC will post 2.79 EPS for the current year.

In other LivaNova news, CFO Thad Allen Huston sold 2,000 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $81.49, for a total transaction of $162,980.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Damien Mcdonald sold 1,000 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $73.82, for a total transaction of $73,820.00. Insiders have sold 14,000 shares of company stock worth $1,118,545 over the last 90 days. 0.41% of the stock is currently owned by company insiders.

LIVN has been the topic of a number of recent analyst reports. BTIG Research reiterated a “hold” rating on shares of LivaNova in a research note on Wednesday, July 31st. Berenberg Bank reiterated a “buy” rating and set a $114.00 price target on shares of LivaNova in a research note on Monday, September 9th. Piper Jaffray Companies set a $90.00 price target on shares of LivaNova and gave the stock a “buy” rating in a research note on Friday, September 6th. BidaskClub lowered shares of LivaNova from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 24th. Finally, ValuEngine upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $98.17.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV”) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients.

Recommended Story: volatile stocks

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.